Education
About Us
Working with TipRanks
Follow Us
Bio-UV Group SA (FR:ALTUV)
:ALTUV
ALTUV Stock Chart & Stats
€1.58
-€0.01(-0.43%)
At close: 4:00 PM EST
€1.58
-€0.01(-0.43%)
Day’s Range― - ―
52-Week Range€1.28 - €2.12
Previous CloseN/A
Volume4.70K
Average Volume (3M)11.56K
Market Cap
€17.92M
Enterprise Value€29.77M
Total Cash (Recent Filing)€9.36M
Total Debt (Recent Filing)€21.11M
Price to Earnings (P/E)20.5
Beta0.48
Next Earnings
Apr 08, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.10
Shares Outstanding14,154,679
10 Day Avg. Volume12,225
30 Day Avg. Volume11,557
Financial Highlights & Ratios
PEG Ratio-9.61
Price to Book (P/B)0.70
Price to Sales (P/S)0.58
P/FCF Ratio4.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Aftermarket & Recurring RevenueA meaningful installed-base aftermarket (lamps, consumables, maintenance and parts) creates recurring, higher-margin cash flows that compound over time. This stabilizes revenue between project cycles, improves lifetime customer value, and supports predictable cash generation and service-led gross margins.
Specialized UV/ozone Tech Across Diversified End-marketsTechnical specialization in UV/ozone with exposure to aquaculture, municipal, industrial and maritime markets provides durable demand drivers. Regulatory and compliance needs in water treatment create structural tailwinds and differentiation vs. generalist competitors, aiding long-run market positioning.
Improving Leverage And Stable Equity RatioRecent improvement in debt metrics and a stable equity ratio indicate better financial flexibility. Reduced leverage risk makes it easier to fund working capital, aftermarket investments and selective capex without excessive refinancing pressure, supporting multi-quarter operational resilience.
Bears Say
Declining Revenue TrendSustained top-line decline undermines scale economics and the growth of higher-margin aftermarket sales. If revenue contraction continues, it pressures utilization of manufacturing and engineering capacity, limits R&D/project pipeline investment, and reduces ability to improve underlying profitability.
Low Net Margins And Weak ROEPersistent weak net margins and minimal ROE indicate limited profitability leverage from revenues. Over the medium term this constrains retained earnings, reduces reinvestment capacity for growth initiatives, and may force reliance on external financing for strategic projects.
Inconsistent Cash Flow ConversionFluctuating FCF and poor OCF-to-net-income conversion weaken internal funding for maintenance, aftermarket service expansion and working capital. Inconsistent cash conversion increases financing risk and limits ability to sustain investments during cyclical or regulatory-driven project demand phases.
Bio-UV Group SA News
ALTUV FAQ
What was Bio-UV Group SA’s price range in the past 12 months?
Bio-UV Group SA lowest stock price was €1.28 and its highest was €2.12 in the past 12 months.
What is Bio-UV Group SA’s market cap?
Bio-UV Group SA’s market cap is €17.92M.
When is Bio-UV Group SA’s upcoming earnings report date?
Bio-UV Group SA’s upcoming earnings report date is Apr 08, 2026 which is in 51 days.
How were Bio-UV Group SA’s earnings last quarter?
Bio-UV Group SA released its earnings results on Sep 18, 2025. The company reported €0.098 earnings per share for the quarter, beating the consensus estimate of N/A by €0.098.
Is Bio-UV Group SA overvalued?
According to Wall Street analysts Bio-UV Group SA’s price is currently Overvalued.
Does Bio-UV Group SA pay dividends?
Bio-UV Group SA pays a Annually dividend of €0.06 which represents an annual dividend yield of N/A. See more information on Bio-UV Group SA dividends here
What is Bio-UV Group SA’s EPS estimate?
Bio-UV Group SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bio-UV Group SA have?
Bio-UV Group SA has 14,154,679 shares outstanding.
What happened to Bio-UV Group SA’s price movement after its last earnings report?
Bio-UV Group SA reported an EPS of €0.098 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.115%.
Which hedge fund is a major shareholder of Bio-UV Group SA?
Currently, no hedge funds are holding shares in FR:ALTUV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bio-UV Group SA
Bio-UV Group SA (ALTUV) specializes in the design and manufacturing of advanced disinfection systems utilizing ultraviolet (UV) technology. Operating primarily in the water treatment and sanitation sectors, the company offers a range of products that cater to various applications, including swimming pools, aquaculture, drinking water, and industrial processes. Bio-UV Group is committed to providing eco-friendly solutions that enhance water quality while minimizing environmental impact.